|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Marketable securities (Notes 3 and 16) | ||||||||||||||||||||
| Trade and other receivables, net, no allowance for credit losses as of June 30, 2026 and December 31, 2025 (Note 4) | ||||||||||||||||||||
| Inventories (Note 5) | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Property, plant and equipment and other assets held for sale, net (Note 7) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Other long-term receivables | ||||||||||||||||||||
| Mineral properties, net (Note 6) | ||||||||||||||||||||
| Convertible note (Notes 3 and 13) | ||||||||||||||||||||
| Property, plant and equipment, net (Note 6) | ||||||||||||||||||||
| Inventory, Noncurrent | ||||||||||||||||||||
| Operating lease right of use asset | ||||||||||||||||||||
| Investments, net (Note 7) | ||||||||||||||||||||
| Marketable securities (Notes 3 and 16) | ||||||||||||||||||||
| Intellectual property, net (Note 8) | ||||||||||||||||||||
| Restricted cash (Note 10) | ||||||||||||||||||||
| Other Assets, Noncurrent | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES & EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable and accrued liabilities (Note 14) | ||||||||||||||||||||
| Asset retirement obligations (Note 10) | ||||||||||||||||||||
| Contingent consideration (Notes 16 and 18) | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Other liabilities (Note 14) | ||||||||||||||||||||
| Deposits for assets held for sale | ||||||||||||||||||||
| Asset retirement obligation and other liabilities held for sale (Note 8) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Convertible senior notes, net (Notes 9 and 16) | ||||||||||||||||||||
| Asset retirement obligations (Note 10) | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Contract with Customer, Liability | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 249,919 and 240,366 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
